Aggregates
Industries in aggregate
Every company grouped by its SEC industry classification, with combined revenue, R&D and capital expenditure across FY2021–FY2025. Click an industry for its companies; click any dot on the scatter for that company.
R&D intensity vs growth, company by company
Each dot is one company. X: R&D as % of FY2024 revenue. Y: revenue change FY2021→FY2024. Hover a dot for the company; click to open its record; drag a box to zoom into a region; double-click to reset.
Min FY2024 revenue Industry
Read it as
- Top-right: heavy R&D and fast growth (young tech, semis).
- Bottom-right: heavy R&D, flat revenue — long-cycle bets (pharma, defense primes).
- Top-left: growth without R&D — commodity-price beneficiaries and rollups.
- Bottom-left: mature, capital-returns businesses.
R&D is as-reported; many industrials expense engineering in cost of revenue, so zero here means “not reported as R&D,” not “no engineering.” Outliers above +250% growth or 40% R&D intensity are clamped to the edge.
All industries
Click an industry name for its full aggregate profile — combined financials, charts, output prices and member companies.
| Industry | Cos. | Revenue FY2024 | Revenue trend | R&D FY2024 | R&D trend | Capex FY2024 | Capex trend | Output prices (BLS PPI) | Largest members |
|---|
Output prices: the BLS producer price index for the matching NAICS industry — rising revenue with flat output prices means volume growth; rising together means pricing. Mapped for ~25 industries where a clean index exists.